G6PD and hepatocellular carcinoma: Moreover, co‐immunoprecipitation assay demonstrated that TSP50 can inhibit the binding of the G6PD protein to acetylase KAT9 while promoting its binding to deacetylase SIRT2 in hepatoma cells (Figure 3G‐I) (Figure S2G‐I).